Company intelligence / Profile preview
Lexaria Bioscience Corp.
Kelowna, British Columbia, Canadalexariabioscience.com ↗
- Ownership
- Public · LEXX
- Employees
- ~7
- Development stage
- Phase 1
01
Overview
Lexaria Bioscience has demonstrated in preclinical and early clinical studies that its DehydraTECH™ platform can significantly increase oral bioavailability of various APIs—including cannabinoids, nicotine analogs, NSAIDs, hormones, PDE5 inhibitors, antivirals, and especially GLP‑1 agonists—while reducing time to onset and improving tolerability. The company has shown positive results in human pharmacokinetic studies with oral forms of semaglutide and liraglutide. Its CBD-hypertension program achieved IND clearance from the FDA.[7]
- Therapeutic areas
- CardiovascularEndocrinologyNeurology
- Modalities
- Small molecules (e.g., cannabinoids, NSAIDs, nicotine)Peptides/proteins (e.g., GLP‑1 drugs, GIP drugs)Hormones[3][9]
- Industry
- Biotech
02
Drug pipeline
15 assets14 more assets in the full pipeline.
03
Partnerships
Multiple licensing agreements with established companies in tobacco/nicotine products as well as cannabinoid beverage/edible manufacturers.[8]H.C. Wainwright & Co. acted as placement agent for recent financing.[5]
04
Financials
- Market cap
- $6.9M
- Total revenue
- $705.9K
- Enterprise value
- $3.4M
Beyond the preview
Go deeper on Lexaria Bioscience Corp..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lexaria Bioscience Corp..